The DOI matches its Crossref record; 865 of the 865 references it cites were found in a registry or an index.
Strategies to Address Low Drug Solubility in Discovery and Development
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Principles of polymer chemistry
(1995) · Choice Reviews Online · doi:10.5860/choice.33-2140 · Cited by 15,218
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
The Cambridge Structural Database: a quarter of a million crystal structures and rising
Allen, F. H. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003890 · Cited by 9,898
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Formation of Glasses from Liquids and Biopolymers
Angell, C. A. (1995) · Science · doi:10.1126/science.267.5206.1924 · Cited by 4,799
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Interfaces and the driving force of hydrophobic assembly
Chandler, D. (2005) · Nature · doi:10.1038/nature04162 · Cited by 3,591
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Fundamental aspects of solid dispersion technology for poorly soluble drugs
Huang, Y., & Dai, W.-G. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.11.001 · Cited by 596
Methods for characterization of nanoparticles
Kumar, A., & Dixit, C. K. (2017) · Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids · doi:10.1016/b978-0-08-100557-6.00003-1 · Cited by 558
Skyner, R. E., McDonagh, J. L., Groom, C. R., van Mourik, T., & Mitchell, J. B. O. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp00288e · Cited by 531
Spray drying formulation of amorphous solid dispersions
Singh, A., & Van den Mooter, G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.010 · Cited by 526
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
Censi, R., & Di Martino, P. (2015) · Molecules · doi:10.3390/molecules201018759 · Cited by 512
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Self-citationImprovement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview
Zhao, J., Yang, J., & Xie, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118642 · Cited by 421
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Self-citationIn vitro models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Abrahamsson, B., Brewster, M., Brouwers, J., Butler, J., Carlert, S., Dickinson, P. A., Dressman, J., Holm, R., Klein, S., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.024 · Cited by 373
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Self-citationTsume, Y., Mudie, D. M., Langguth, P., Amidon, G. E., & Amidon, G. L. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.01.009 · Cited by 350
Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review
Yu, D.-G., Li, J.-J., Williams, G. R., & Zhao, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.016 · Cited by 341
Davidov-Pardo, G., & McClements, D. J. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.05.003 · Cited by 337
McClements, D. J. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.004 · Cited by 322
McClements, D. J., Li, F., & Xiao, H. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032814-014043 · Cited by 315
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
The Prodrug Approach: A Successful Tool for Improving Drug Solubility
Jornada, D., Dos Santos Fernandes, G., Chiba, D., De Melo, T., Dos Santos, J., & Chung, M. (2015) · Molecules · doi:10.3390/molecules21010042 · Cited by 294
Ionic liquids as a potential tool for drug delivery systems
Adawiyah, N., Moniruzzaman, M., Hawatulaila, S., & Goto, M. (2016) · MedChemComm · doi:10.1039/c6md00358c · Cited by 292
Mirza, M. U., & Froeyen, M. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.04.008 · Cited by 284
Carboxymethyl cellulose-based oral delivery systems
Javanbakht, S., & Shaabani, A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.079 · Cited by 281
Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development
He, Y., & Ho, C. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24541 · Cited by 272
Jeliński, T., Przybyłek, M., & Cysewski, P. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2643-2 · Cited by 259
Emerging frontiers of deep eutectic solvents in drug discovery and drug delivery systems
Zainal-Abidin, M. H., Hayyan, M., Ngoh, G. C., Wong, W. F., & Looi, C. Y. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.09.019 · Cited by 254
Thomas, N., Richter, K., Pedersen, T. B., Holm, R., Müllertz, A., & Rades, T. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9589-4 · Cited by 111
Yeap, Y. Y., Trevaskis, N. L., Quach, T., Tso, P., Charman, W. N., & Porter, C. J. H. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3006566 · Cited by 83
Self-citationMoghadam, S., & Larson, R. G. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00942 · Cited by 52
Alskär, L. C., Parrow, A., Keemink, J., Johansson, P., Abrahamsson, B., & Bergström, C. A. S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.038 · Cited by 36
Amphiphilic block copolymers–based micelles for drug delivery
Imran, M., Shah, M. R., & Shafiullah (2018) · Design and Development of New Nanocarriers · doi:10.1016/b978-0-12-813627-0.00010-7 · Cited by 35
Ilie, A.-R., Griffin, B. T., Brandl, M., Bauer-Brandl, A., Jacobsen, A.-C., Vertzoni, M., Kuentz, M., Kolakovic, R., & Holm, R. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105452 · Cited by 33
“…between free drug (i.e. molecularly dissolved) and drug bound as its colloidal associates, given it has been suggested that free drug can permeate across biological or artificial membranes, whereas drug solubilised within colloidal species may not (Williams et al., 2013b; Berben et al., 2018).”
BackgroundSardana, K., Khurana, A., & Gupta, A. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1604218 · Cited by 28
Halder, A., & Khopade, A. J. (2020) · Clinical ophthalmology · doi:10.2147/opth.s266453 · Cited by 12
Metadata
- Authors
- Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 315-499
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2133061394
- Cited by
- 1,570
- References
- 865
- FWCI
- 56.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.